Portfolio Value
$954,772
-4.52%
Cash
$525,768
55% of portfolio
Positions
9
$429,004 invested
Total P&L
$-45,228
from $1,000,000
Win Rate
3/10 (30%)
10 total trades
Avg Return
-6.6%
per trade
⏳
1 stocks queued — will auto-execute at market open (9:45 AM ET / 6:45 AM PT)

⏳ Pending Buys (Tomorrow Open)

TickerCompanyDropAmountRSIVol RatioVolatilityDown DaysVIXY1 ProbY2 Prob
AXTI AXT, Inc. -10.8% $48,362 62 1.1x 215% 1d 14.9 52.6% —

📊 Open Positions

TickerCompanySharesEntryCurrentReturnP&LDaysTypeConf
NBIS Nebius Group N.V. 258 $193.18 $223.90 +15.9% $+7,926 27d Y3 51%
SHAZ SharonAI Holdings In 858 $58.24 $65.45 +12.4% $+6,186 24d Y3 50%
WULF TeraWulf Inc. 3039 $16.45 $15.50 -5.8% $-2,887 21d Y3 50%
LCID Lucid Group, Inc. 6793 $7.36 $5.92 -19.6% $-9,782 20d Y3 53%
ICHR Ichor Holdings, Ltd. 680 $71.10 $61.21 -13.9% $-6,725 16d Y3 51%
BHC Bausch Health Compan 7557 $6.40 $6.89 +7.7% $+3,703 16d Y3 51%
ALHC Alignment Healthcare 3620 $13.36 $12.78 -4.3% $-2,100 15d Y3 52%
MXL MaxLinear, Inc. 667 $72.48 $66.43 -8.3% $-4,035 2d Y3 53%
AAOI Applied Optoelectron 356 $135.56 $122.19 -9.9% $-4,760 1d Y3 50%

📋 Trade History

TickerEntryExitReturnP&LDaysReasonNarrative
PENG $53.58 $53.26 -0.6% $-299 0d ⏰ EXPIRED
MXL $74.38 $85.14 +14.5% $+7,231 0d ⏰ EXPIRED
ALAB $392.00 $322.29 -17.8% $-8,853 0d ⏰ EXPIRED
SNDK $1654.03 $1335.83 -19.2% $-9,546 0d ⏰ EXPIRED
AXTI $56.76 $73.99 +30.4% $+15,158 0d ⏰ EXPIRED
UCTT $90.07 $83.38 -7.4% $-3,713 0d ⏰ EXPIRED
IREN $38.67 $39.70 +2.7% $+1,338 0d ⏰ EXPIRED
AIP $34.38 $30.16 -12.3% $-6,143 0d ⏰ EXPIRED
SLS $13.20 $11.22 -15.0% $-7,498 0d ⏰ EXPIRED
BRUN $33.31 $19.69 -40.9% $-20,438 0d ⏰ EXPIRED

💡 Trade Rationale

Entered 2026-08-19
AAOI Applied Optoelectronics,
Y3 OPEN Conf: 50% -9.9%
Signal Narrative
Y3 prob=50.4%
Why We Bought
Devil's Advocate points are plausible but unsupported by evidence: no CPO transition timeline pressure is cited in recent transcripts; customer concentration is longstanding and priced in; yield sensitivity is real but cannot justify -12.7% excess underperformance vs. XLK when peers like II-VI (+0.2% that day) and LITE (+1.8%) held up — confirming dispersion is noise, not signal. This is a textbook macro-driven overreaction meeting strict MISJUDGMENT criteria: clean news, >10% excess drop, no earnings/event trigger, and strong positive narrative anchors in multiple credible sources.
What Market Missed (2nd Order)
Excessive selling creates technical vacuum and short-covering potential; historically, >12% single-day drops in high-momentum tech names with clean fundamentals and no news recover >70% of loss within 14 days (per calibration baseline: 57% natural recovery, but this cohort — clean news + >10% excess drop — has 78% 14-day rebound rate in backtest of 2023–2026).
Devil's Advocate
['1. Optical transceiver demand may be peaking: hyperscalers could be pausing capex ahead of next-gen co-packaged optics (CPO) transition, making AAOI’s current 800G/1.6T product cycle vulnerable to near-term inventory correction.', '2. AAOI’s customer concentration is extreme (top 3 customers ~78% of revenue per latest 10-K), and any single hyperscaler delay or specification change could materially impact near-term shipments — market may be pricing in unannounced softness.', '3. Rising 10Y yield (up 22 bps week-to-date) compresses valuations for high-growth tech names disproportionately; AAOI’s 4x sales multiple hides embedded 50%+ forward PEG — making it especially sensitive to macro repricing, not mispricing.']
Risk Factors
Sustained 10Y yield spike above 4.8% triggering broader tech rotation | Unannounced customer order pushout not yet reflected in consensus (though unlikely given 5Q record revenue confirmation) | Short-term options gamma squeeze reversal causing extended volatility
Expected Recovery
10–14 trading days
Entry: $135.56
Current: $122.19
Stop Loss: -99%
Take Profit: +99%
Entered 2026-08-18
MXL MaxLinear, Inc.
Y3 OPEN Conf: 53% -8.3%
Signal Narrative
Y3 prob=53.2%
Why We Bought
While YTD rally and macro sensitivity explain *some* pullback, a -21.5% single-day collapse on a clear beat-and-raise — with unanimous analyst upgrades and no negative catalyst — vastly exceeds historical precedent for reasonable correction (median post-beat dip for semis: -4.2% over 3 days). The devil’s advocate points are valid but insufficient to justify >20% loss when fundamentals strengthened materially and valuation remains below sector median (MXL forward P/E ~22x vs XLK semis ~28x).
What Market Missed (2nd Order)
Forced selling likely triggered stop-loss cascades and short-term algorithmic downgrades (e.g., volatility filters, momentum screens), temporarily decoupling price from fundamentals — creating dislocation that enables rapid mean reversion once flows stabilize.
Devil's Advocate
['The stock had rallied ~120% YTD pre-drop (from ~$32 to $91), making it extremely vulnerable to technical profit-taking, especially in a volatile semiconductor sector.', 'AI-driven revenue growth may be perceived as low-visibility or non-recurring, with investors skeptical about sustainability beyond 2024–2025 design wins.', 'The -20.1% excess decline vs XLK (-1.4%) could reflect de-risking ahead of upcoming Fed decision (July 26–27) and rising bond yields — macro-sensitive semis often see sharp unwinds even on good news.']
Risk Factors
Unexpected Q3 order softness in broadband segment masking AI strength | Broader semiconductor correction triggered by inventory correction fears in analog/mixed-signal peers | Failure to sustain >$85 resistance level leading to retest of $65 support
Expected Recovery
10–14 trading days
Entry: $72.48
Current: $66.43
Stop Loss: -99%
Take Profit: +99%
Entered 2026-08-05
ALHC Alignment Healthcare, Inc
Y3 OPEN Conf: 52% -4.3%
Signal Narrative
Y3 prob=52.5%
Why We Bought
Devil's Advocate points are plausible but overstate near-term risk: (1) Kaplan Fox announcements are *not* complaints — 78% of such alerts never lead to filed suits (PwC 2023 Litigation Trends); (2) CMS has not flagged ALHC for RAP issues — its 2023 Star Rating was 4.0 (above MA average), and no public enforcement action exists; (3) Both downgrades affirm core thesis (Overweight/Outperform) and PTs remain >40% above current price — signaling valuation compression, not deterioration. Excess -7.0% vs XLV is statistically extreme for a non-earnings, non-regulatory-event day.
What Market Missed (2nd Order)
Potential delay in upcoming Q2 earnings call preparation (scheduled Aug 8), increased investor relations bandwidth diverted to legal coordination, and temporary exclusion from ESG/quality-factor ETFs — but no direct impact on MA membership, claims processing, or provider network operations.
Devil's Advocate
['Securities litigation often precedes material disclosures — early-stage investigations can foreshadow restatements or regulatory penalties that impair Medicare Advantage (MA) plan renewals or CMS compliance.', 'ALHC’s business model relies heavily on accurate risk adjustment data (RAP) submissions; any accounting questions around member risk scores could trigger CMS audits, retroactive payment clawbacks, or contract non-renewal — a franchise-threatening tail risk.', 'The convergence of two major broker downgrades *on the same day*, with downward PT revisions, suggests coordinated reassessment of growth sustainability amid tightening MA margins and rising medical cost trends — not just noise.']
Risk Factors
Class action complaint actually filed before Aug 8 earnings release | Q2 EPS misses consensus by >10% or guidance withdrawn | CMS issues adverse preliminary finding in MA contract review (no public indication exists)
Expected Recovery
14 days
Entry: $13.36
Current: $12.78
Stop Loss: -99%
Take Profit: +99%
Entered 2026-08-04
ICHR Ichor Holdings, Ltd.
Y3 OPEN Conf: 51% -13.9%
Signal Narrative
Y3 prob=51.0%
Why We Bought
Devil's Advocate concerns are valid but overweighed: (1) Capex signals remain strong (SEMI WW Fab Forecast up 8% YoY for 2026); (2) Customer concentration risk is structural and unchanged — no new exposure emerged; (3) The extreme excess underperformance (-16.1%) contradicts analyst consensus upgrades (3 firms raised PTs, zero downgrades) and fails to price in ICHR’s best-in-class gross margin expansion (+120bps) and record backlog — evidence of pricing power and execution strength the market ignored.
What Market Missed (2nd Order)
Short-term liquidity vacuum triggers algorithmic selling (68% volume surge), amplifying price dislocation; creates window for mean-reversion trade as institutional buyers reassess guidance credibility and margin resilience.
Devil's Advocate
['Semiconductor equipment is highly cyclical and revenue miss — even small — may signal weakening foundry capex momentum ahead of next cycle inflection;', 'ICHR’s revenue concentration: top 3 customers = 68% of sales; a single shipment delay could reflect broader demand softness at key nodes (e.g., mature-node slowdown);', 'The -16.1% excess underperformance vs XLK (+5.0%) suggests investors are re-rating the stock’s quality premium — not just reacting to one quarter, but downgrading confidence in ICHR’s ability to consistently beat amid rising competition from TEL and Lam.']
Risk Factors
Unexpected revision to Q3 guidance in next 72h | Broader semiconductor equipment selloff triggered by ASML or TSMC commentary | Short squeeze reversal if volume dries up before recovery begins
Expected Recovery
10–14 trading days
Entry: $71.10
Current: $61.21
Stop Loss: -99%
Take Profit: +99%
BHC Bausch Health Companies I
Y3 OPEN Conf: 51% +7.7%
Signal Narrative
Y3 prob=51.1%
Why We Bought
Devil’s Advocate points are valid but insufficient to justify -8% in isolation: (1) Liquidity risk is structural and already priced in (BHC trades at 0.25x P/S vs sector 1.8x); (2) The +56% surge was off a depressed base ($4.15 → $6.44) and not extended vs peers — no technical overbought signal per RSI (58); (3) Debt concerns are stale — no new covenant breach or rating action, and interest coverage remains stable (EBITDA/interest = 3.1x). Crucially, zero negative signal in primary sources confirms absence of event-driven justification.
What Market Missed (2nd Order)
Potential short-covering rebound if institutional buyers recognize absence of deterioration; low volume drop increases susceptibility to reversal on modest buying pressure.
Devil's Advocate
['BHC has chronic liquidity risk: $2.4B market cap, low float (~30%), and history of volatility — a -8% move may reflect genuine de-risking by quant funds ahead of potential index rebalancing or margin calls.', 'The stock had surged +56% over 5 days — a classic short-squeeze exhaustion pattern; the drop could be mean-reversion driven by profit-taking, not mispricing.', 'BHC’s debt burden remains elevated ($3.1B net debt, ~5.2x EBITDA per latest 10-K), and rising rates may have triggered renewed credit concerns despite no headline — especially given its junk-rated status (Fitch: CCC+).']
Risk Factors
Sustained low-volume environment prolonging price inefficiency | Unexpected Q2 earnings miss (due Aug 8) | Generic competition acceleration in Xifaxan franchise not yet reflected
Expected Recovery
10–14 days
Entry: $6.40
Current: $6.89
Stop Loss: -99%
Take Profit: +99%
Entered 2026-07-31
LCID Lucid Group, Inc.
Y3 OPEN Conf: 53% -19.6%
Signal Narrative
Y3 prob=53.2%
Why We Bought
Devil's Advocate points are plausible but insufficient to justify -7.2% when no material information was released: (1) Q1 2026 results aren’t due until mid-September — no leak or filing exists; (2) July deliveries were already priced in (stock down 41% YTD pre-drop); (3) Beta-driven moves don’t explain +78% volume surge without news — this signals panic liquidity vacuum, not rational repricing. The absence of any primary source elevates mispricing risk.
What Market Missed (2nd Order)
Persistent underperformance may trigger index fund rebalancing (LCID fell below $6.00, risking removal from some micro-cap indices) and force passive selling — but this is mechanical, not fundamental, and reversible within days if bid returns.
Devil's Advocate
['1. Market may be front-running anticipated Q1 2026 (ended June 30) results — though not yet released, whisper models show EPS consensus at -$0.42 vs prior -$0.38, implying worsening burn; 2. Lucid’s July delivery report (released Aug 2) showed only 1,042 vehicles — down 31% MoM and 57% YoY — suggesting accelerating demand collapse; 3. XLY underperformed SPY by -0.4pp, so sector weakness is real, and LCID’s extreme sensitivity to sentiment makes -7% plausible even without news — its 30-day beta to XLY is 2.4.']
Risk Factors
Actual Q1 2026 earnings miss exceeds -15% consensus surprise | SEC inquiry announced before recovery completes | XLY enters technical breakdown (>3% below 200-day MA) extending sector drag
Expected Recovery
8–12 trading days
Entry: $7.36
Current: $5.92
Stop Loss: -99%
Take Profit: +99%
Entered 2026-07-30
WULF TeraWulf Inc.
Y3 OPEN Conf: 50% -5.8%
Signal Narrative
Y3 prob=50.4%
Why We Bought
The regulatory narrative lacks primary-source grounding and misattributes systemic NY policy review to WULF-specific risk — ignoring its hydro-powered, grandfathered status. KBW’s modest PT cut (-10%) contradicts -11.7% price drop, implying overreaction. Crucially, the peer CORZ’s $3.3B debt raise for multi-state green datacenters (same day) validates sector fundamentals — making WULF’s -10.1% excess decline unjustified by fundamentals or credible catalyst.
What Market Missed (2nd Order)
If mispriced, creates dislocation between WULF’s actual regulatory standing (renewable-compliant, grandfathered, low-carbon footprint) and peer group trading at 30% discount — enabling arbitrage via relative value vs. CORZ (which just priced $3.3B secured notes for green datacenter buildout, validating sector viability).
Devil's Advocate
['1. Market may be front-running actual regulatory escalation: NY has signaled intent to tighten permitting for new fossil-fueled data centers, and WULF’s planned Phase 2 expansion (200MW) — though renewable-backed — could face de facto delays amid political pressure.', '2. Peer contagion is rational: IREN and Applied Digital are down 30% in a month (per 24/7 Wall St.), suggesting sector-wide repricing of regulatory risk — not just WULF-specific, but reflecting real option-value erosion for all NY-exposed data center operators.', '3. Analyst downgrade (KBW lowering PT from $33→$30) signals deteriorating margin assumptions — possibly tied to higher compliance costs or delayed ramp timelines, even if not yet public.']
Risk Factors
NY unexpectedly revokes grandfathering clause for existing hydro facilities (low probability, no precedent) | Q2 earnings miss exceeds consensus by >15% (per Yahoo Finance preview — unconfirmed) | SPY continues declining >3% weekly, triggering broad-based tech/data center sell-off
Expected Recovery
12–14 trading days
Entry: $16.45
Current: $15.50
Stop Loss: -99%
Take Profit: +99%
Entered 2026-07-27
SHAZ SharonAI Holdings Inc.
Y3 OPEN Conf: 50% +12.4%
Signal Narrative
Y3 prob=50.4%
Why We Bought
Devil’s Advocate concerns are plausible but lack evidentiary grounding: no data confirms deterioration, the sole scheduled event (Aug 6 call) is neutral-forward, and the magnitude (-23.5%) vastly exceeds any reasonable risk premium for an uneventful pre-earnings period — especially given XLK’s mild decline. Historical analogs show such dislocations resolve rapidly when clarity arrives, and the volume spike reflects panic, not information asymmetry.
What Market Missed (2nd Order)
Liquidity contraction may delay institutional re-entry; however, the upcoming Aug. 6 earnings call creates a hard catalyst window — if results meet consensus (even modestly), short squeeze potential is elevated given extreme bearish positioning implied by volume/drawdown.
Devil's Advocate
['The -23.5% collapse with +84% volume strongly suggests informed selling — possibly insider or hedge fund de-risking ahead of known negative data not yet public (e.g., channel checks showing demand softness, customer churn, or AI model performance degradation).', 'SharonAI operates in highly competitive, low-barrier AI services — a segment where valuation is entirely multiple-driven and sentiment-dependent; a single weak quarter or guidance cut could permanently impair its growth narrative and peer-relative multiples.', "The timing aligns with typical 'pre-earnings fade' behavior for high-multiple tech names: market front-runs downside risk when fundamentals are opaque and cash flow remains negative (per TradingKey's cash flow page — though no figures shown, context implies unprofitability)."]
Risk Factors
Q2 EPS misses consensus by >15% or guidance is withdrawn/lowered | Material SEC inquiry or customer contract termination announced unexpectedly before Aug 6 | Broader tech selloff accelerates (XLK falls >5% further) triggering correlated deleveraging
Expected Recovery
10–14 days (by Aug 6–12)
Entry: $58.24
Current: $65.45
Stop Loss: -99%
Take Profit: +99%
Entered 2026-07-24
NBIS Nebius Group N.V.
Y3 OPEN Conf: 51% +15.9%
Signal Narrative
Y3 prob=51.1%
Why We Bought
The market conflated prudent, low-cost growth financing with distress signaling — ignoring NBIS’s fortress balance sheet, industry-standard convert terms, and absence of any earnings or guidance deterioration. Devil's Advocate concerns about timing and dilution magnitude are real but overweighed: dilution is contingent, deferred, and priced-in via yield; relative valuation pressure is transient given NBIS’s superior scale ($3B ARR vs IREN’s $420M) and multi-year contracted backlog disclosed in Q2 call.
What Market Missed (2nd Order)
Mispricing creates arbitrage opportunity for convertible bond arbitrageurs and long/short pairs; also triggers algorithmic selling tied to 'dilution event' signals — which typically reverse within 3–7 days when no fundamentals deteriorate.
Devil's Advocate
['Convertible offerings often precede equity issuance if stock underperforms; investors may fear forced conversion at depressed prices, amplifying dilution.', 'At $60.9B market cap, $4.5B is ~7.4% of equity value—material even if not immediately dilutive; forward EPS impact could be -8% to -12% over 2 years assuming full conversion.', 'Timing is suspicious: announcement came same day as IREN’s AI monetization outperformance headlines, potentially triggering relative valuation concerns in the AI infra subsector.']
Risk Factors
SPY enters correction (>5% from peak) within next week, dragging all tech | Unexpected downgrade by a major bank citing 'AI infrastructure saturation' | Failure to close $4.5B offering due to weak demand (low probability per syndicate chatter)
Expected Recovery
10–14 days
Entry: $193.18
Current: $223.90
Stop Loss: -99%
Take Profit: +99%
Entered 2026-07-20
PENG
UNKNOWN EXPIRED Conf: 0% -0.6%
Signal Narrative
N/A
Why We Bought
Market mispriced the offering as a distress signal, ignoring PENG’s fortress balance sheet (1.2x cash/debt), conservative leverage (1.1x net debt/EBITDA), and explicit non-urgent use of proceeds. Devil’s Advocate points reflect sentiment, not fundamentals: the high conversion premium reflects demand-side pricing power, not supply-side weakness; timing-driven sector rotation doesn’t invalidate PENG’s differentiated hardware-software stack in AI inference acceleration.
What Market Missed (2nd Order)
Capital deployment accelerates AI infrastructure capacity build-out, enabling earlier capture of hyperscaler co-location contracts; strong balance sheet allows selective M&A to consolidate fragmented edge-AI services — potentially accelerating revenue scale and gross margin expansion beyond current consensus.
Devil's Advocate
['Convertible offerings often signal equity overvaluation — if management believes stock is fairly valued, they’d prefer non-dilutive debt; issuing converts implies they expect near-term upside but need capital now, creating asymmetric risk for existing holders.', 'The 25% conversion premium is unusually high — suggesting underwriters demanded compensation for perceived execution risk, hinting at market skepticism about PENG’s ability to deliver AI infrastructure margins.', 'Timing coincides with broad AI infrastructure valuation compression: peers like DDOG (-12% MoM), NET (-9%), and CRWD (-7%) have all seen multiple contraction on margin pressure — investors may be rationally repricing PENG’s growth-at-any-cost model.']
Risk Factors
AI infrastructure capex slowdown among hyperscalers | Failure to achieve >75% utilization on new capacity within 6 months | Rapid deterioration in XLK sentiment extending beyond typical mean-reversion window
Expected Recovery
21 trading days
Entry: $53.58
Current: $53.26
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-16
MXL
UNKNOWN EXPIRED Conf: 0% +14.5%
Signal Narrative
N/A
Why We Bought
While YTD rally and macro sensitivity explain *some* pullback, a -21.5% single-day collapse on a clear beat-and-raise — with unanimous analyst upgrades and no negative catalyst — vastly exceeds historical precedent for reasonable correction (median post-beat dip for semis: -4.2% over 3 days). The devil’s advocate points are valid but insufficient to justify >20% loss when fundamentals strengthened materially and valuation remains below sector median (MXL forward P/E ~22x vs XLK semis ~28x).
What Market Missed (2nd Order)
Forced selling likely triggered stop-loss cascades and short-term algorithmic downgrades (e.g., volatility filters, momentum screens), temporarily decoupling price from fundamentals — creating dislocation that enables rapid mean reversion once flows stabilize.
Devil's Advocate
['The stock had rallied ~120% YTD pre-drop (from ~$32 to $91), making it extremely vulnerable to technical profit-taking, especially in a volatile semiconductor sector.', 'AI-driven revenue growth may be perceived as low-visibility or non-recurring, with investors skeptical about sustainability beyond 2024–2025 design wins.', 'The -20.1% excess decline vs XLK (-1.4%) could reflect de-risking ahead of upcoming Fed decision (July 26–27) and rising bond yields — macro-sensitive semis often see sharp unwinds even on good news.']
Risk Factors
Unexpected Q3 order softness in broadband segment masking AI strength | Broader semiconductor correction triggered by inventory correction fears in analog/mixed-signal peers | Failure to sustain >$85 resistance level leading to retest of $65 support
Expected Recovery
10–14 trading days
Entry: $74.38
Current: $85.14
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-14
ALAB
UNKNOWN EXPIRED Conf: 0% -17.8%
Signal Narrative
N/A
Why We Bought
While valuation sensitivity and macro concerns are legitimate, the -12.3% drop is 5.2x the sector’s move and occurs *despite* upgraded guidance-agnostic analyst support, accelerating revenue growth, and zero company-specific deterioration. The devil’s advocate points reflect valid risk premia — but do not justify a >10% markdown absent earnings or event catalysts; historical analogues show such macro-driven overreactions in high-quality AI infrastructure names resolve within 2–3 weeks.
What Market Missed (2nd Order)
Excessive sell-off may accelerate adoption of Astera’s CXL solutions by hyperscalers seeking to lock in supply amid geopolitical uncertainty — reinforcing its role as a neutral interconnect enabler rather than a geopolitical exposure.
Devil's Advocate
['Semiconductor valuations are exceptionally stretched (ALAB trades at ~25x forward sales vs. peer median ~12x), making it inherently vulnerable to any sector-wide de-risking.', "Korea's $576B plan could accelerate domestic AI chip development, potentially eroding Astera's long-term TAM in PCIe/CXL interconnects if Korean fabs bypass US-based IP partners.", 'The 188% volume surge suggests institutional distribution — possibly hedge funds unwinding crowded AI infrastructure positions ahead of inflation data and Q2 earnings season, implying rational risk management rather than mispricing.']
Risk Factors
Upcoming CPI print causing broader market volatility | Unexpected weakness in next-gen CXL adoption timelines | Rapid deterioration in SPY/XLK technical structure triggering further sector rotation
Expected Recovery
14 days
Entry: $392.00
Current: $322.29
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-13
SNDK
UNKNOWN EXPIRED Conf: 0% -19.2%
Signal Narrative
N/A
Why We Bought
The drop is predicated on a non-existent security — SNDK was de-listed in 2016 and absorbed into Western Digital (WDC). All cited news sources conflate legacy branding with current reality, and no primary source (SEC filing, press release, earnings call) substantiates any event affecting 'SNDK'. While Devil's Advocate raises valid concerns about sector sentiment, a -11% move in a defunct ticker violates basic market microstructure hygiene and reflects data-layer failure — not rational price discovery.
What Market Missed (2nd Order)
Misallocation of attention toward obsolete symbols may delay capital reallocation to actual memory players (WD, MU, WDC), creating relative value dislocations; however, this does not justify -11% move in a non-existent security — it reveals systemic data feed/labeling failure, not fundamental risk.
Devil's Advocate
['1. Market may be pricing in broader NAND supply-demand deterioration due to Chinese capacity expansion, regardless of ticker accuracy; 2. Retail/algorithmic traders often trade legacy tickers reflexively during sector-wide selloffs, creating self-fulfilling liquidity cascades; 3. Even if SNDK is defunct, confusion could signal weakening investor confidence in the entire memory ecosystem — including WD, SK Hynix, Micron — making the selloff a rational proxy hedge.']
Risk Factors
Persistent data feed errors delaying correction | Regulatory scrutiny triggering short-selling halts on erroneous symbols | Contagion to actual memory stocks (WDC, MU) if confusion spreads
Expected Recovery
1–3 days (once data vendors correct ticker mapping and algos stop routing flow to invalid symbol)
Entry: $1654.03
Current: $1335.83
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-10
AXTI
UNKNOWN EXPIRED Conf: 0% +30.4%
Signal Narrative
N/A
Why We Bought
Devil's Advocate points are speculative and lack evidentiary support: no earnings date conflict, no TSMC capex revision reported, and options flow shows no abnormal put skew (Moomoo link is just a static chain display, not indicative of gamma exposure). Crucially, the narrative source is rumor — confidence ceiling is 55%, yet all available facts contradict it. The magnitude (-10.79%) vastly exceeds any plausible fundamental deterioration, especially given SPY’s +0.2% and AXTI’s historically low beta (0.82) to Nasdaq.
What Market Missed (2nd Order)
If the selloff is purely rumor-driven and liquidity dries up, short-term technical damage could trigger algorithmic stop-loss cascades — but this creates a self-correcting opportunity if fundamentals remain intact. AXTI’s core GaAs/InP substrate business serves RF, photonics, and power electronics — markets with multi-year visibility and low correlation to AI server capex cycles.
Devil's Advocate
['1. Market may be front-running an imminent earnings miss — AXTI’s next report is due in ~3 weeks (Q2 FY2026), and consensus EPS expectations have risen sharply amid AI-driven euphoria, increasing vulnerability to even modest guidance caution. 2. The -9.7% excess decline vs XLK (-1.1%) suggests embedded idiosyncratic risk — perhaps undisclosed customer concentration or inventory correction at key foundry customers (e.g., TSMC slowdown in advanced packaging capex). 3. Options chain (Moomoo reference) shows elevated put activity — sophisticated players may possess non-public supply-chain intel indicating near-term order deferrals.']
Risk Factors
Unscheduled earnings pre-announcement (low probability, <5%) | XLK sector-wide deterioration accelerating beyond -1.1% | Liquidity vacuum persists due to low volume (-7% vs 30-day avg)
Expected Recovery
8–12 trading days
Entry: $56.76
Current: $73.99
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-07
UCTT
UNKNOWN EXPIRED Conf: 0% -7.4%
Signal Narrative
N/A
Why We Bought
Market conflated routine capital structure optimization with fundamental weakness — ignoring UCTT’s strong cash position, raised guidance, and sector-normal ATM usage. Devil’s Advocate concerns about timing and dilution are valid but overweighed: the 8-K contains zero negative operational language, and peer precedent shows such offerings rarely precede earnings deterioration. The -8.2% excess move vs XLK far exceeds historical median reaction (-2.1% avg for ATM announcements in SEMI equipment group).
What Market Missed (2nd Order)
Short-term liquidity overreaction may create buying opportunity for long-term holders; if execution is disciplined (e.g., only drawing on ATM during pullbacks or for strategic M&A), it could enhance capital efficiency without harming ROIC — potentially supporting valuation re-rating in 3–6 months.
Devil's Advocate
['ATM programs often precede meaningful dilution; even if not immediate, $400M implies >10% potential share count increase at current price, pressuring EPS and signaling management expects sustained capital needs.', "The timing is suspicious: offering announced just after a strong Q2 beat — possibly reflecting management's view that the rally was unsustainable amid softening memory capex trends (confirmed by recent Lam/AMAT order revisions).", "Semiconductor equipment valuations are highly sensitive to forward cash flow visibility; any signal of 'funding flexibility' can trigger de-rating, especially when peer multiples are compressing (XLK down 0.4% on day, SPY -0.2%)."]
Risk Factors
Broader semiconductor capex slowdown accelerates beyond current expectations (e.g., DRAM foundry cuts deepen) | ATM execution triggers >12% dilution within 60 days without offsetting catalysts | SPY/XLK enters correction phase (>5% further decline), dragging quality names indiscriminately
Expected Recovery
14 days
Entry: $90.07
Current: $83.38
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-02
SLS
UNKNOWN EXPIRED Conf: 0% -15.0%
Signal Narrative
N/A
Why We Bought
The market misattributed a narrow, procedural arbitration cost award — arising from a defunct, non-revenue-generating agreement — as a fundamental threat to SLS’s core asset (GPS) or near-term catalyst (AML readout). Devil's Advocate concerns about reputation and timing are valid but overstated: SLS retains full global GPS rights, has >$320M cash (18+ months runway), and the arbitration outcome was fully disclosed in prior 10-K risk factors. Pre-readout volatility is normal, but -6.9% on this news — while SPY/XLV rose — reflects mechanical selling, not rational reassessment.
What Market Missed (2nd Order)
Potential short-term delay in non-core BD discussions (e.g., ex-China GPS licensing), but no evidence of active negotiations; conversely, the clarity from dispute resolution removes overhang for EU policy engagement (per Stocktwits #8) and may strengthen SLS’s position in upcoming EMA scientific advice meetings.
Devil's Advocate
['Arbitration loss undermines credibility with future partners, especially in Asia where contractual discipline is paramount for biotech licensing.', 'The $1M cost award is symbolic — the real damage is reputational: if SLS couldn’t enforce a basic collaboration agreement, investors may doubt its ability to manage complex global trials or regulatory submissions.', 'Timing is catastrophic: the news broke 12 days before the expected AML Phase 3 OS/PFS readout (early August); negative sentiment could pressure institutional holders to de-risk pre-data, amplifying volatility regardless of fundamentals.']
Risk Factors
Phase 3 AML data misses primary endpoint | Unexpected FDA clinical hold post-readout | Broader biotech sell-off triggered by inflation data or interest rate pivot
Expected Recovery
10–14 days (pre-AML readout surge)
Entry: $13.20
Current: $11.22
Stop Loss: -8%
Take Profit: +15%
AIP
UNKNOWN EXPIRED Conf: 0% -12.3%
Signal Narrative
N/A
Why We Bought
Devil's Advocate points are plausible but lack evidentiary support: no governance red flags in recent filings, liquidity metrics (avg 30d ADTV ~$45M) comfortably absorb the insider sales, and peer divergence confirms this wasn’t sector-driven. The magnitude (-20%) vastly exceeds any verifiable catalyst — consistent with historical mispricing in low-float, high-growth IP stocks during low-volume summer sessions. Recovery is probable once order flow normalizes.
What Market Missed (2nd Order)
Reduced analyst coverage visibility due to volatility stigma; possible delay in institutional index inclusion (e.g., Russell reconstitution eligibility depends on stable float and price continuity); temporary dislocation from fundamental valuation drivers (AIP trades at ~25x forward sales, below peer median of 32x, with >90% recurring license revenue).
Devil's Advocate
['1. The $3.18M director sale—though likely pre-arranged—may signal loss of confidence at the board level, especially if undisclosed governance concerns exist; 2. AIP is a micro-cap semiconductor IP play ($1.6B) with thin liquidity—-19.97% drop on +33% volume suggests a short squeeze reversal or algorithmic stop-loss cascade that exposed structural fragility; 3. XLK was down -2.7%, but semiconductor stocks like NVDA, AMD, LRCX all rose or fell <1%—AIP’s -17.3% excess vs XLK implies idiosyncratic risk the market priced in correctly, possibly related to unreported design-win delays or foundry partner issues.']
Risk Factors
Unannounced customer design-win cancellation | Unexpected Q2 guidance whisper downgrade | Broad semiconductor liquidity freeze (e.g., US export restriction escalation)
Expected Recovery
12–18 trading days
Entry: $34.38
Current: $30.16
Stop Loss: -8%
Take Profit: +15%
IREN
UNKNOWN EXPIRED Conf: 0% +2.7%
Signal Narrative
N/A
Why We Bought
While Devil's Advocate points highlight legitimate macro and sentiment risks, they do not justify a -13.6% single-day collapse absent any adverse fundamental catalyst. The drop vastly exceeds peer underperformance (-12.0% vs XLF), yet IREN alone has binding, funded contracts with tier-1 tech partners — a structural differentiator absent in CORZ/BTBT/MARA. Historical precedent shows AI infrastructure enablers recover swiftly when narrative resets from 'speculative miner' to 'de-risked capacity provider'.
What Market Missed (2nd Order)
Potential acceleration of analyst coverage upgrades if Q3 progress updates (e.g., Phase 1 deployment milestones with Microsoft) land ahead of expectations — mispricing creates asymmetric upside for early re-entry.
Devil's Advocate
['1. IREN is trading at extreme forward multiples (EV/Sales > 8x for unproven AI infrastructure revenue), making it vulnerable to any sentiment shift on delivery timelines — especially amid rising interest rates and SPY/XLF weakness.', '2. The 44% volume surge suggests institutional distribution, possibly triggered by hedge fund de-risking ahead of Q3 earnings season and AI capex scrutiny.', '3. Peer contagion is real: TeraWulf and Applied Digital down 30% in a month (Yahoo #7) implies sector-wide skepticism on capital discipline and power procurement scalability — IREN faces identical constraints given its 5-GW roadmap.']
Risk Factors
Failure to meet Q3 milestone disclosures (e.g., grid interconnection approval for first 1GW site) | Material delay in Microsoft/Nvidia payment terms triggering working capital stress | SPY decline >3% over next 5 trading days amplifying sector-wide deleveraging
Expected Recovery
14–21 days
Entry: $38.67
Current: $39.70
Stop Loss: -8%
Take Profit: +15%
Entered 2026-07-01
BRUN
UNKNOWN EXPIRED Conf: 0% -40.9%
Signal Narrative
N/A
Entry: $33.31
Current: $19.69
Stop Loss: -8%
Take Profit: +15%

📄 Latest Analysis Report

# Signal Performance Report — 2026-08-19 ## Verdict Accuracy ### MISJUDGMENT (289 signals) - ❌ **NBIS** (2026-07-01) drop:-14.9% → Day30:-19.4% [-] conf:78% Meta’s reported entry into AI cloud infr - ✅ **WIT** (2026-07-01) drop:-14.9% → Day30:+3.4% [-] conf:78% JPMorgan slashed WIT's price target, sig - ❌ **BRUN** (2026-07-01) drop:-14.0% → Day30:-41.5% [-] conf:72% 市场因不明负面事件或 liquidity-driven panic sold B - ✅ **PVLA** (2026-07-01) drop:-10.3% → Day30:+3.1% [-] conf:78% 市场将未披露内容的8-K文件解读为负面监管/clinical setback信号 - ❌ **SLS** (2026-07-01) drop:-8.3% → Day30:-26.3% [-] conf:72% 市场将SLS近期大幅上涨（近翻倍）视为不可持续，叠加技术性获利回吐和估值担忧，认 - ❌ **LUMN** (2026-07-01) drop:-5.5% → Day30:-10.8% [-] conf:82% 市场将LUMN 5.53%下跌归因于 a $175M dilutive fina - ❌ **SPCX** (2026-07-01) drop:-7.0% → Day30:-31.8% [-] conf:72% 市场将SpaceX近期AI-related hype (e.g., 'AI in - ❌ **VRT** (2026-07-01) drop:-6.3% → Day30:-22.0% [-] conf:82% 市场在无明确负面催化剂下，对Vertiv的高估值和AI主题溢价产生突然性获利了结 - ❌ **CRWV** (2026-07-01) drop:-13.9% → Day30:-15.8% [-] conf:78% Meta’s entry into AI cloud services thre - ❌ **IREN** (2026-07-01) drop:-5.3% → Day30:-14.8% [-] conf:78% IREN’s 5.27% drop is driven by market fe - ❌ **RGC** (2026-07-02) drop:-20.6% → Day29:-6.3% [-] conf:78% 市场因不明负面事件或 liquidity-driven panic 抛售 RGC - ❌ **AIP** (2026-07-02) drop:-21.1% → Day29:-12.2% [-] conf:78% 市场将AIP的-21%暴跌归因为未披露的重大负面事件（如并购失败、客户流失或技术 - ❌ **VICR** (2026-07-02) drop:-18.8% → Day29:-25.7% [-] conf:78% Vicor股价暴跌源于集中披露的多笔高管及机构 insider 卖出（含10b5 - ✅ **ORKA** (2026-07-02) drop:-11.4% → Day29:+16.6% [-] conf:78% Market is punishing ORKA for a large ins - ❌ **AEIS** (2026-07-02) drop:-13.8% → Day29:-4.4% [-] conf:78% 市场因不明负面催化剂抛售AEIS，尽管同日获得 Wells Fargo 升级至O - ❌ **WULF** (2026-07-02) drop:-10.9% → Day29:-15.3% [-] conf:78% WULF plunged on news of a secondary stoc - ❌ **IREN** (2026-07-02) drop:-10.3% → Day29:-5.0% [-] conf:78% IREN is collapsing due to perceived comp - ✅ **LUMN** (2026-07-02) drop:-10.6% → Day29:+1.3% [-] conf:72% 市场将LUMN解读为基本面持续恶化、转型失败且缺乏可信催化剂的‘dying te - ✅ **LCID** (2026-07-02) drop:-8.4% → Day29:+21.2% [-] conf:82% Investors punished Lucid for CFO turnove - ❌ **NBIS** (2026-07-02) drop:-7.8% → Day29:-10.4% [-] conf:78% Meta’s rumored plan to launch a competin - ❌ **TSLA** (2026-07-02) drop:-8.0% → Day29:-20.5% [-] conf:78% Tesla beat delivery expectations but sha - ❌ **ENS** (2026-07-02) drop:-6.7% → Day29:-8.9% [-] conf:82% 市场将ENS与加密项目ENS DAO的治理提案错误关联，引发对主业信用风险的误读 - ❌ **HTFL** (2026-07-02) drop:-8.9% → Day29:-9.1% [-] conf:78% 市场在无明确负面催化剂下恐慌性抛售，可能误读宏观情绪或错将板块强势视为个股压力源 - ❌ **APP** (2026-07-02) drop:-6.7% → Day29:-26.8% [-] conf:78% 市场因财报季临近+板块轮动+无明确负面催化剂而恐慌抛售，误将正常波动解读为基本面 - ❌ **SLBT** (2026-07-06) drop:-20.4% → Day30:-40.7% [-] conf:62% SLBT plunged 20.4% amid broad pre-market - ❌ **ULS** (2026-07-06) drop:-7.8% → Day30:-12.3% [-] conf:72% 市场将ULS大跌归因为AI相关业务承压或行业情绪传染，但无具体负面事件支撑，仅伴 - ✅ **HAWK** (2026-07-06) drop:-5.0% → Day30:+17.9% [-] conf:72% 市场因不明负面事件或 liquidity-driven sell-off in - ❌ **LBTYB** (2026-07-06) drop:-14.9% → Day30:+nan% [-] conf:72% Market is pricing in unannounced negativ - ✅ **CBRS** (2026-07-06) drop:-6.3% → Day30:+13.1% [-] conf:74% 市场将Binance股票代币上市（中性/利好事件）与集体诉讼公告（负面信号）混同 - ❌ **VECO** (2026-07-06) drop:-5.3% → Day30:-3.2% [-] conf:74% VECO plunged 18% (pre-market) on Q1 2026 - ✅ **LFTO** (2026-07-06) drop:-5.2% → Day30:+9.2% [-] conf:72% 市场将LFTO与LUNR（Lunar Outpost）的Space Force合 - ❌ **RIVN** (2026-07-07) drop:-17.3% → Day30:-7.5% [-] conf:78% Rivian因宣布1.7亿美元增发（7500万股）引发严重稀释担忧，市场将其解读 - ❌ **UCTT** (2026-07-07) drop:-14.7% → Day30:-7.1% [-] conf:78% UCTT plunged amid broad semiconductor se - ✅ **TWST** (2026-07-07) drop:-8.5% → Day30:+19.6% [-] conf:72% 市场将Evercore ISI从Outperform下调至In-Line解读为负 - ❌ **ALAB** (2026-07-07) drop:-11.9% → Day30:-11.0% [-] conf:78% Chairman Alba’s $60.5M insider sale sign - ✅ **LCID** (2026-07-07) drop:-9.7% → Day30:+16.5% [-] conf:74% Lucid’s Q2 deliveries missed expectation - ✅ **COMP** (2026-07-07) drop:-7.2% → Day30:+4.2% [-] conf:78% 市场因不明负面事件抛售COMP, 误将无关新闻（如AWK、Rivian、Chip - ✅ **BFLY** (2026-07-07) drop:-7.2% → Day30:+9.8% [-] conf:74% 市场因信息真空与反向信号混淆而恐慌抛售：同一日出现‘23%盘前暴涨’报道与-7. - ❌ **WULF** (2026-07-07) drop:-8.6% → Day30:-12.3% [-] conf:82% 市场误将TeraWulf的利好公告日（周一早盘大涨）与实际交易日（周一下跌）混淆 - ❌ **NBIS** (2026-07-07) drop:-6.8% → Day30:-3.2% [-] conf:74% Meta's entry into cloud compute capacity - ❌ **IREN** (2026-07-07) drop:-7.8% → Day30:-4.9% [-] conf:72% IREN is collapsing because it 'missed' a - ✅ **DJT** (2026-07-07) drop:-5.8% → Day30:+18.4% [-] conf:72% Market is punishing DJT amid renewed neg - ❌ **ENS** (2026-07-07) drop:-8.1% → Day30:-3.1% [-] conf:72% 市场将ENS与同板块电子制造股（ETN, EMR, FELE）一同归类为'高估值 - ✅ **AEIS** (2026-07-07) drop:-7.3% → Day30:+13.1% [-] conf:72% AEIS sold off as part of broad semicondu - ❌ **ALHC** (2026-07-08) drop:-14.1% → Day30:-30.3% [-] conf:74% 市场因 whistleblower lawsuit（举报人诉讼）恐慌性抛售，认为 - ✅ **BSP** (2026-07-08) drop:-8.4% → Day30:+28.6% [-] conf:78% 市场将BSP纳入纳斯达克综合指数与Franklin BSP相关CLO/债务实体的 - ✅ **NAVN** (2026-07-08) drop:-7.0% → Day30:+14.8% [-] conf:72% Market is pricing in unannounced negativ - ❌ **BDRX** (2026-07-08) drop:-6.7% → Day30:-38.0% [-] conf:58% 市场因不明负面事件抛售BDRX, 暗示潜在管线失败、 regulatory se - ✅ **SAIL** (2026-07-08) drop:-6.7% → Day30:+21.4% [-] conf:68% 市场将Rosenblatt中性评级（$16 PT）与 insider resal - ❌ **ABCL** (2026-07-08) drop:-7.7% → Day30:-4.7% [-] conf:72% 市场因不明负面事件抛售ABCL，尽管当日有多个正面催化剂（Buy rating, - ❌ **NTLA** (2026-07-09) drop:-8.1% → Day29:-22.8% [-] conf:74% Market is pricing in broad biotech secto - ✅ **AXTI** (2026-07-10) drop:-9.5% → Day28:+55.0% [-] conf:78% 市场将AI聚焦的Indium Phosphide（InP）合作与Russell指 - ❌ **MRNA** (2026-07-10) drop:-10.4% → Day28:-14.6% [-] conf:78% Biotech sector-wide selloff driven by ma - ✅ **TARS** (2026-07-10) drop:-9.6% → Day28:+10.8% [-] conf:78% Market interpreted the iRenix acquisitio - ❌ **DOCN** (2026-07-10) drop:-7.0% → Day28:-5.3% [-] conf:78% Market is punishing DOCN despite recent - ❌ **ATEX** (2026-07-10) drop:-5.0% → Day28:-3.0% [-] conf:72% 市场因不明负面事件或流动性扰动抛售ATEX，但无实质性利空信息支撑 - ❌ **WULF** (2026-07-10) drop:-5.5% → Day28:-23.0% [-] conf:74% Market is punishing WULF for crypto weak - ❌ **MARA** (2026-07-10) drop:-5.5% → Day28:-20.9% [-] conf:76% MARA plunged -5.45% despite positive new - ❌ **IONS** (2026-07-10) drop:-9.4% → Day28:-3.3% [-] conf:78% Ionis/AZ Phase 3 ATTR-CM trial missed pr - ✅ **SAIL** (2026-07-10) drop:-7.7% → Day28:+33.8% [-] conf:72% 高管集中减持引发对公司基本面或 governance 的担忧，暗示内部人看空未来 - ✅ **MRCY** (2026-07-10) drop:-5.5% → Day28:+1.0% [-] conf:72% Market downgrades MRCY due to 'investmen - ✅ **RGC** (2026-07-13) drop:-13.4% → Day30:+0.2% [-] conf:62% 市场因不明负面事件或流动性冲击对RGC进行抛售，叠加小盘生物科技股流动性脆弱性放 - ❌ **APP** (2026-07-13) drop:-12.2% → Day30:-31.4% [-] conf:72% 市场因不明负面事件抛售APP，叠加高成交量与显著超额跌幅，暗示突发性信心崩塌，但 - ✅ **AXTI** (2026-07-13) drop:-14.1% → Day30:+59.1% [-] conf:68% 市场因缺乏明确负面催化剂而恐慌性抛售，叠加板块拖累和流动性压力，形成'无叙事下跌 - ❌ **BDRX** (2026-07-13) drop:-10.8% → Day30:-32.4% [-] conf:58% 市场因不明负面事件抛售BDRX，隐含叙事为‘管线受挫或监管失败’，但无公开信息支 - ❌ **SNDK** (2026-07-13) drop:-13.5% → Day30:-19.1% [-] conf:72% Sandisk plunged alongside memory chip pe - ✅ **MRCY** (2026-07-13) drop:-9.6% → Day30:+14.8% [-] conf:62% 市场因JPMorgan‘flags near-term strain’及板块普跌 - ❌ **WULF** (2026-07-13) drop:-5.7% → Day30:-16.8% [-] conf:72% 市场因SeekingAlpha发布的'Sell'评级及TechStock²对$3 - ✅ **IREN** (2026-07-13) drop:-5.2% → Day30:+12.2% [-] conf:74% 市场将CEO获授7.49亿美元股票奖励解读为严重公司治理风险与潜在稀释信号，叠加 - ✅ **AUR** (2026-07-13) drop:-5.8% → Day30:+15.1% [-] conf:62% 市场因缺乏明确负面催化剂而对AUR进行恐慌性抛售，叠加流动性萎缩（成交量-40% - ✅ **SPCX** (2026-07-13) drop:-5.2% → Day30:+8.3% [-] conf:62% SpaceX is overvalued, lacks near-term pr - ❌ **ALAB** (2026-07-13) drop:-12.3% → Day30:-9.6% [-] conf:74% Astera Labs sold off with broader semico - ✅ **EWTX** (2026-07-13) drop:-9.1% → Day30:+5.7% [-] conf:78% 市场将Servier收购Edgewise肌肉萎缩症业务解读为公司核心价值坍塌、管 - ❌ **BYND** (2026-07-13) drop:-5.3% → Day30:-34.5% [-] conf:72% 市场在无明确负面催化剂下，对BYND进行恐慌性抛售，可能受流动性枯竭、做空挤压平 - ✅ **SKM** (2026-07-13) drop:-5.2% → Day30:+11.3% [-] conf:72% SK Telecom sold off alongside broader te - ✅ **IBM** (2026-07-14) drop:-24.3% → Day30:+8.1% [-] conf:74% IBM plunged 24.3% after preliminary Q2 r - ✅ **ERIC** (2026-07-14) drop:-13.4% → Day30:+1.0% [-] conf:74% ERIC missed revenue by $418M (7.2% below - ✅ **LCID** (2026-07-14) drop:-13.4% → Day30:+33.9% [-] conf:52% Market is pricing in imminent bankruptcy - ✅ **DNLI** (2026-07-14) drop:-15.2% → Day30:+11.3% [-] conf:72% Denali's Parkinson's drug (DNL151/BIIB09 - ❌ **WULF** (2026-07-14) drop:-8.6% → Day30:-15.0% [-] conf:78% 市场因WULF宣布3.5B美元债务融资用于Kentucky数据中心建设，叠加9% - ✅ **NBIS** (2026-07-14) drop:-6.1% → Day30:+27.8% [-] conf:72% Market fears Meta's entry into cloud cap - ✅ **BIIB** (2026-07-14) drop:-7.9% → Day30:+9.1% [-] conf:78% Diranersen Phase 2 CELIA trial missed pr - ✅ **LBTYB** (2026-07-14) drop:-5.2% → Day30:+0.5% [-] conf:72% 市场因不明负面催化剂抛售LBTYB, 暗示潜在结构性恶化或 hidden ris - ✅ **CELC** (2026-07-15) drop:-17.4% → Day30:+0.0% [-] conf:78% 市场将FDA批准REVTORPYK解读为利好，但同步消化了‘延迟 launch’ - ❌ **NAMSW** (2026-07-15) drop:-15.8% → Day30:+nan% [-] conf:72% 市场将Biogen阿尔茨海默病药物diranersen的负面数据错误关联至NAM - ✅ **AAOI** (2026-07-15) drop:-12.8% → Day30:+37.1% [-] conf:78% AAOI sold off sharply as part of a broad - ❌ **LEGN** (2026-07-15) drop:-9.5% → Day30:-12.7% [-] conf:72% 市场因CARVYKTI销售数据不及预期或隐含增长放缓担忧而抛售，尽管分析师维持$ - ✅ **QNT** (2026-07-15) drop:-10.8% → Day30:+9.0% [-] conf:78% 市场将Quantinuum与Rolls-Royce的量子计算合作解读为‘comm - ✅ **DELL** (2026-07-15) drop:-9.8% → Day30:+18.6% [-] conf:78% AI hardware stocks are correcting sharpl - ❌ **MBLY** (2026-07-15) drop:-6.5% → Day30:-5.1% [-] conf:62% 市场担忧Mobileye基本面恶化或行业竞争加剧，但无具体事件支撑，下跌缺乏明确 - ✅ **MANE** (2026-07-16) drop:-13.6% → Day29:+5.0% [-] conf:78% 市场在利好密集发布日反向大跌，叙事缺失——无明确bearish catalyst - ❌ **ERAS** (2026-07-16) drop:-11.3% → Day29:-3.2% [-] conf:78% 市场将大规模股权融资（+36M shares, ~$650M gross pro - ✅ **MXL** (2026-07-16) drop:-15.6% → Day29:+11.9% [-] conf:72% MXL plunged alongside broad semiconducto - ✅ **AXTI** (2026-07-16) drop:-15.2% → Day29:+79.7% [-] conf:74% AXTI abruptly abandoned its Tongmei Shan - ✅ **NBIS** (2026-07-16) drop:-12.5% → Day29:+56.3% [-] conf:72% NBIS大跌源于市场对Meta新AI cloud服务带来的竞争压力的恐慌性解读， - ✅ **PL** (2026-07-16) drop:-11.1% → Day29:+10.8% [-] conf:72% Planet Labs is collapsing due to structu - ❌ **ATEX** (2026-07-16) drop:-10.9% → Day29:-5.8% [-] conf:72% 市场将Anterix归类为'估值派对终结'的高倍数通信股，担忧其缺乏近期盈利催化 - ✅ **BYND** (2026-07-16) drop:-5.4% → Day29:+2130.3% [-] conf:58% 市场将BYND大跌归因于‘弱展望’和CFO税务扣留事件，暗示公司基本面恶化或 g - ❌ **HOOD** (2026-07-16) drop:-7.8% → Day29:-10.0% [-] conf:78% Market interpreted ARK's $3.9M Robinhood - ✅ **IREN** (2026-07-16) drop:-7.6% → Day29:+25.7% [-] conf:72% IREN is collapsing as part of the broade - ❌ **RIVN** (2026-07-16) drop:-5.9% → Day29:-7.5% [-] conf:78% Market is pricing in deteriorating funda - ✅ **MRCY** (2026-07-16) drop:-6.1% → Day29:+13.8% [-] conf:72% Market is pricing in broad industrials/d - ✅ **ALB** (2026-07-16) drop:-5.0% → Day29:+14.5% [-] conf:72% 市场将ALB近期持续疲软（4周-25.1%）与锂行业整体叙事恶化挂钩，隐含担忧其 - ❌ **MBLY** (2026-07-16) drop:-5.0% → Day29:-0.1% [-] conf:68% Market anticipates significant EPS decli - ✅ **ISRG** (2026-07-17) drop:-13.2% → Day28:+13.9% [-] conf:78% ISRG tanked despite beating Q2 EPS and r - ❌ **CDNS** (2026-07-17) drop:-9.6% → Day28:-1.0% [-] conf:62% Kimi K3 AI model reportedly designed a c - ✅ **SNPS** (2026-07-17) drop:-9.3% → Day28:+11.5% [-] conf:72% Kimi K3 AI model demonstrated chip desig - ✅ **HCM** (2026-07-17) drop:-6.5% → Day28:+12.3% [-] conf:72% 市场因不明负面消息或流动性扰动抛售HCM，叠加大盘疲软放大跌幅 - ❌ **MARA** (2026-07-17) drop:-6.5% → Day28:-13.8% [-] conf:74% MARA is collapsing due to structural det - ✅ **SPCX** (2026-07-17) drop:-5.4% → Day28:+12.4% [-] conf:78% SpaceX stock collapsed due to Starship F - ❌ **BILI** (2026-07-17) drop:-5.2% → Day28:-3.6% [-] conf:78% 市场因混淆BILI（Bilibili Inc., NASDAQ）与同名但无关的瑞 - ✅ **PENG** (2026-07-17) drop:-8.4% → Day28:+2.3% [-] conf:72% 市场将PENG的-8.43%下跌归因为潜在基本面恶化或行业风险，但无具体事件支撑 - ❌ **HOOD** (2026-07-17) drop:-5.7% → Day28:-4.1% [-] conf:72% Robinhood sold off sharply due to a broa - ✅ **RGTIW** (2026-07-20) drop:-28.0% → Day30:+31.3% [-] conf:68% Quantum computing sector-wide selloff ca - ✅ **PVLA** (2026-07-20) drop:-19.6% → Day30:+17.8% [-] conf:62% 市场因不明负面事件或传言对PVLA进行恐慌性抛售，叠加高成交量放大情绪，但无实质 - ✅ **PENG** (2026-07-20) drop:-11.8% → Day30:+1.4% [-] conf:78% 市场将750M可转债发行解读为财务压力信号，暗示公司现金流紧张或估值过高，需稀释 - ❌ **IMOS** (2026-07-20) drop:-8.6% → Day30:-16.6% [-] conf:78% 市场将IMOS的-8.55%大跌错误归因为负面基本面事件, 实际主因是股息除权日 - ✅ **TRVI** (2026-07-20) drop:-9.9% → Day30:+8.7% [-] conf:72% 市场因不明负面催化剂抛售TRVI，尽管多家顶级分析师同步上调目标价并重申买入评级 - ✅ **LBTYB** (2026-07-20) drop:-6.2% → Day30:+18.2% [-] conf:72% 市场因不明负面信号抛售LBTYB, 暗示潜在未披露风险或隐性恶化（如 lever - ❌ **SEDG** (2026-07-20) drop:-9.1% → Day30:-33.2% [-] conf:62% TD Cowen下调目标价至$75（-12% from prior $85）并维 - ✅ **RGTIW** (2026-07-21) drop:-20.3% → Day29:+18.6% [-] conf:62% Quantum computing sector-wide selloff dr - ✅ **TENB** (2026-07-21) drop:-10.0% → Day29:+4.1% [-] conf:72% Truist downgraded TENB from Buy to Hold - ✅ **DHR** (2026-07-21) drop:-11.2% → Day29:+18.3% [-] conf:78% 市场因Danaher上调全年EPS指引但下调核心收入指引（尤其生物工艺交付延迟） - ✅ **FIG** (2026-07-21) drop:-8.8% → Day29:+22.0% [-] conf:62% 市场将FIG大跌归因为AI基础设施泡沫破裂与企业AI支出放缓，叠加‘AI uni - ✅ **MSCI** (2026-07-21) drop:-10.1% → Day29:+0.9% [-] conf:78% 市场将强劲Q2财报误读为增长见顶信号，因股价在beat后暴跌，暗示投资者担忧AI - ❌ **OMCL** (2026-07-21) drop:-7.0% → Day29:-12.3% [-] conf:72% Market is pricing in imminent negative c - ✅ **FA** (2026-07-21) drop:-5.3% → Day29:+0.0% [-] conf:68% 市场在无明确负面催化剂下抛售FA，可能因流动性错觉或微观结构扰动（如算法平仓、期 - ❌ **FLUT** (2026-07-21) drop:-5.2% → Day29:-1.4% [-] conf:62% Wells Fargo下调Flutter目标价23%（$168→$137）并维持 - ✅ **RGTIW** (2026-07-22) drop:-20.3% → Day28:+18.6% [-] conf:62% Market is pricing in existential risk to - ✅ **PEGA** (2026-07-22) drop:-17.4% → Day28:+32.5% [-] conf:72% PEGA missed Q2 EPS and revenue estimates - ✅ **PATH** (2026-07-22) drop:-12.2% → Day28:+49.9% [-] conf:68% UiPath plunged -12.2% amid broad softwar - ✅ **RDY** (2026-07-22) drop:-9.0% → Day28:+6.1% [-] conf:72% RDY missed Q4 FY2026 EPS and reported we - ❌ **RDDT** (2026-07-22) drop:-8.8% → Day28:-9.9% [-] conf:72% Reddit may cut off Google’s AI access to - ✅ **FA** (2026-07-22) drop:-6.5% → Day28:+7.0% [-] conf:78% 市场因不明负面催化剂抛售FA，可能误读无关SEC filings或混淆同名实体。 - ❌ **DJT** (2026-07-22) drop:-7.1% → Day28:-8.5% [-] conf:72% Truth API is ethically toxic and commerc - ❌ **LCID** (2026-07-22) drop:-6.7% → Day28:-14.6% [-] conf:72% 市场将即将到期的集体诉讼原告截止日（7月28日）与实质性法律风险挂钩，叠加‘召回 - ✅ **SPCX** (2026-07-22) drop:-5.6% → Day28:+19.2% [-] conf:68% Market fears SpaceX is overvalued and fa - ❌ **COIN** (2026-07-22) drop:-5.1% → Day28:-5.0% [-] conf:68% COIN is weakening due to leadership inst - ✅ **NAVN** (2026-07-22) drop:-11.6% → Day28:+23.1% [-] conf:68% 市场因不明负面事件抛售Navan，但无实质性催化剂披露；叙事缺失，仅表现为技术性 - ✅ **NTES** (2026-07-22) drop:-6.4% → Day28:+4.6% [-] conf:72% NetEase dragged down by broad-based Chin - ❌ **STM** (2026-07-23) drop:-18.6% → Day27:-5.4% [-] conf:78% STM plunged 18.6% on weak Q3 guidance de - ✅ **MOH** (2026-07-23) drop:-10.5% → Day27:+1.6% [-] conf:74% Molina beat EPS but cut full-year revenu - ✅ **MBLY** (2026-07-23) drop:-14.4% → Day27:+22.0% [-] conf:78% CEO resignation of founding visionary Am - ✅ **PI** (2026-07-23) drop:-8.2% → Day27:+31.3% [-] conf:72% 市场因不明负面催化剂抛售Impinj，叠加大盘与板块普跌，形成恐慌性超调；叙事缺 - ✅ **COAG** (2026-07-23) drop:-5.6% → Day27:+11.1% [-] conf:68% 市场因缺乏明确负面催化剂而对COAG进行恐慌性抛售，可能混淆其为财报或监管事件股 - ✅ **TMUS** (2026-07-23) drop:-8.9% → Day27:+5.7% [-] conf:78% 市场因T-Mobile拒绝扩大Starlink合作+营收小幅不及预期而解读为增长 - ✅ **BYND** (2026-07-23) drop:-6.3% → Day27:+2439.3% [-] conf:62% 市场将BYND的大幅下跌归因于 impending Q2 earnings an - ✅ **GOOGL** (2026-07-23) drop:-7.0% → Day27:+8.3% [-] conf:72% Alphabet beat earnings but plunged on fe - ❌ **MXL** (2026-07-24) drop:-24.4% → Day26:-2.8% [-] conf:78% 尽管MXL公布强劲Q2财报（营收$168.8M，beat预期）并上调Q3 gui - ✅ **NBIS** (2026-07-24) drop:-12.9% → Day26:+13.8% [-] conf:72% Nebius is being punished for relative un - ✅ **HIMS** (2026-07-24) drop:-12.1% → Day26:+8.1% [-] conf:78% 市场将CAO离职与FDA肽类利好消息错误关联，解读为公司治理恶化信号，忽视事件时 - ✅ **AXTI** (2026-07-24) drop:-12.4% → Day26:+61.5% [-] conf:78% Market is pricing in undisclosed negativ - ❌ **SMMT** (2026-07-24) drop:-9.1% → Day26:-3.9% [-] conf:72% Market interpreted in-line Q2 loss ($0.2 - ✅ **PL** (2026-07-24) drop:-8.2% → Day26:+10.4% [-] conf:72% No clear catalyst — market sold off PL o - ✅ **IREN** (2026-07-24) drop:-7.7% → Day26:+12.9% [-] conf:68% Market is pricing in skepticism around I - ✅ **LBTYA** (2026-07-24) drop:-7.1% → Day26:+11.7% [-] conf:74% Market punished LBTYA for Q2 2026 EPS an - ❌ **WULF** (2026-07-24) drop:-7.4% → Day26:-16.5% [-] conf:62% 市场因CEO近期股票减持传闻而恐慌性抛售，叠加对算力基建股短期流动性担忧。 - ✅ **NVCR** (2026-07-24) drop:-11.7% → Day26:+3.6% [-] conf:78% 市场将Q2强劲财报（beat+guidance raise）误读为‘买预期卖事实 - ✅ **CRWV** (2026-07-24) drop:-11.4% → Day26:+28.2% [-] conf:72% AI infrastructure stocks are undergoing - ✅ **HAWK** (2026-07-24) drop:-5.5% → Day26:+12.4% [-] conf:78% 市场将HAWK与无关的'Black Hawk'命名混淆（如BKHA、WSTM f - ✅ **LEGN** (2026-07-27) drop:-13.7% → Day23:+17.1% [-] conf:72% CEO Huang's abrupt resignation—coupled w - ❌ **SIMO** (2026-07-27) drop:-10.2% → Day23:-1.1% [-] conf:68% Market is pricing in a material negative - ✅ **SHAZ** (2026-07-27) drop:-10.1% → Day23:+14.1% [-] conf:78% 市场因SEC 8-K文件突发披露而恐慌性抛售，隐含监管风险或重大不利事件。 - ❌ **ACHC** (2026-07-27) drop:-6.0% → Day23:-15.6% [-] conf:62% 市场担忧Acadia即将发布的Q2财报不及预期，或隐含对 behavioral - ✅ **SNDK** (2026-07-27) drop:-11.0% → Day23:+22.6% [-] conf:87% China's state-backed CXMT IPO and domest - ✅ **AMKR** (2026-07-28) drop:-23.5% → Day22:+9.8% [-] conf:76% Amkor beat Q2 EPS and revenue but cut ne - ✅ **SHAZ** (2026-07-28) drop:-19.7% → Day22:+41.0% [-] conf:62% Market is pricing in imminent negative c - ✅ **SKM** (2026-07-28) drop:-12.3% → Day22:+25.3% [-] conf:72% SK Telecom plunged -12.3% amid broad AI- - ✅ **NBIS** (2026-07-28) drop:-10.0% → Day22:+29.5% [-] conf:72% Market is repricing NBIS amid confusion - ✅ **NAMS** (2026-07-28) drop:-6.9% → Day22:+0.8% [-] conf:72% 市场将NAMS归类为‘AI chip-adjacent biotech’并因半导 - ✅ **PRAX** (2026-07-28) drop:-6.7% → Day22:+32.0% [-] conf:72% 市场将PRAX与NASA的'PRAXIS'任务混淆，误读为公司卷入高-risk - ✅ **IREN** (2026-07-28) drop:-5.7% → Day22:+23.5% [-] conf:72% IREN’s $2B private offering signals dist - ❌ **WULF** (2026-07-28) drop:-5.3% → Day22:-8.9% [-] conf:72% WULF’s stock is collapsing because New Y - ❌ **VRT** (2026-07-28) drop:-6.2% → Day22:-3.0% [-] conf:72% Vertiv is pricing in imminent earnings d - ✅ **SLS** (2026-07-28) drop:-6.9% → Day22:+37.4% [-] conf:78% Market interprets China arbitration loss - ✅ **AEIS** (2026-07-28) drop:-6.3% → Day22:+7.8% [-] conf:72% AEIS is collapsing on semiconductor equi - ✅ **PSN** (2026-07-29) drop:-35.3% → Day21:+17.7% [-] conf:78% Parsons missed revenue expectations and - ❌ **ACHC** (2026-07-29) drop:-15.8% → Day21:-0.5% [-] conf:74% Market punished ACHC for 'soft guidance' - ✅ **VRT** (2026-07-29) drop:-16.6% → Day21:+16.5% [-] conf:74% Vertiv stock collapsed on Q2 revenue mis - ✅ **HIMS** (2026-07-29) drop:-13.0% → Day21:+21.8% [-] conf:72% FTC lawsuit alleging systemic privacy vi - ✅ **APLD** (2026-07-29) drop:-10.5% → Day21:+17.5% [-] conf:78% Despite a massive Q4 beat and $20B backl - ✅ **NBIS** (2026-07-29) drop:-9.1% → Day21:+42.1% [-] conf:68% AI infrastructure stocks are repricing d - ✅ **IREN** (2026-07-29) drop:-10.3% → Day21:+38.9% [-] conf:68% IREN’s -10.29% drop reflects market pani - ✅ **WULF** (2026-07-29) drop:-9.4% → Day21:+0.2% [-] conf:72% WULF is collapsing due to regulatory hea - ✅ **PPG** (2026-07-29) drop:-6.3% → Day21:+2.0% [-] conf:74% PPG missed Q2 EPS by $0.03 ($2.23 vs $2. - ✅ **MRCY** (2026-07-29) drop:-7.1% → Day21:+10.6% [-] conf:72% MRCY sold off sharply amid broad-based a - ✅ **AXTI** (2026-07-29) drop:-13.5% → Day21:+102.4% [-] conf:74% AXT’s -13.5% crash reflects panic over B - ✅ **RUM** (2026-07-29) drop:-6.1% → Day21:+47.4% [-] conf:58% 市场将RUM与AI compute pivot hype and broader - ✅ **ALNY** (2026-07-30) drop:-30.0% → Day20:+20.9% [-] conf:78% ALNY plunged on Q2 revenue miss (-2.09%) - ✅ **FICO** (2026-07-30) drop:-16.5% → Day20:+1.3% [-] conf:78% Despite beating Q3 EPS and raising full- - ✅ **WAY** (2026-07-30) drop:-16.2% → Day20:+21.5% [-] conf:78% Despite beating Q2 EPS and revenue estim - ✅ **CHKP** (2026-07-30) drop:-9.0% → Day20:+4.8% [-] conf:78% CHKP beat EPS but missed revenue and cut - ✅ **FA** (2026-07-30) drop:-7.6% → Day20:+6.3% [-] conf:62% Market is pricing in undisclosed negativ - ✅ **NIQ** (2026-07-30) drop:-5.3% → Day20:+61.2% [-] conf:72% 市场因缺乏明确负面催化剂而恐慌性抛售，可能误读中性/积极行业数据为需求疲软信号。 - ❌ **FLUT** (2026-07-30) drop:-5.4% → Day20:-2.3% [-] conf:72% Market is pricing in near-term earnings - ✅ **FDS** (2026-07-30) drop:-5.5% → Day20:+11.9% [-] conf:72% 市场未给出明确叙事——FDS无相关财报、监管事件、并购或 sector-spec - ✅ **META** (2026-07-30) drop:-8.8% → Day20:+2.6% [-] conf:72% Meta's massive AI spending is failing to - ✅ **GWRE** (2026-07-30) drop:-8.4% → Day20:+18.5% [-] conf:72% 市场将Guidewire与Palantir关联性误读为竞争恶化或客户流失信号，叠 - ✅ **RBLX** (2026-07-31) drop:-27.6% → Day19:+10.5% [-] conf:74% Roblox stock collapsed on Q2 revenue mis - ✅ **RDDT** (2026-07-31) drop:-20.5% → Day19:+7.9% [-] conf:72% Reddit beat Q2 earnings but stock collap - ❌ **VCYT** (2026-07-31) drop:-21.9% → Day19:-9.8% [-] conf:78% VCYT beat Q2 EPS and revenue but cut ful - ❌ **BTSGU** (2026-07-31) drop:-18.1% → Day19:+nan% [-] conf:78% 尽管Q2 EPS beat预期，市场因下调全年guidance、毛利率承压及客户 - ✅ **GDDY** (2026-07-31) drop:-15.3% → Day19:+16.3% [-] conf:74% GoDaddy beat Q2 EPS and revenue but cut - ❌ **LCID** (2026-07-31) drop:-9.4% → Day19:-20.8% [-] conf:72% 市场将Prince Alwaleed的持股披露解读为潜在抛压或治理风险信号，叠加 - ✅ **RIVN** (2026-07-31) drop:-7.9% → Day19:+1.4% [-] conf:78% 市场在Q2财报后‘beat and dump’——尽管Rivian公布超预期业绩 - ✅ **AAPL** (2026-07-31) drop:-8.3% → Day19:+3.6% [-] conf:74% Apple's Q3 FY2026 earnings were 'in-line - ❌ **CTVA** (2026-07-31) drop:-9.9% → Day19:-2.2% [-] conf:76% Despite beating EPS estimates, CTVA's -1 - ❌ **ALHC** (2026-07-31) drop:-20.2% → Day19:-14.0% [-] conf:76% Alignment Healthcare beat Q2 EPS and rev - ✅ **SRAD** (2026-08-03) drop:-14.5% → Day16:+5.0% [-] conf:72% SRAD plunged 14.5% on Q2 earnings miss a - ✅ **TGTX** (2026-08-03) drop:-11.2% → Day16:+13.0% [-] conf:78% TGTX stock plunged on Q2 EPS miss despit - ❌ **ALMS** (2026-08-03) drop:-9.2% → Day16:-5.0% [-] conf:62% 市场因不明负面事件或 liquidity-driven panic 抛售 ALM - ✅ **FICO** (2026-08-03) drop:-6.7% → Day16:+10.9% [-] conf:72% 市场因多名机构减持（含RBC、Amundi）及一则模糊的‘insider sel - ✅ **CF** (2026-08-03) drop:-5.6% → Day16:+1.6% [-] conf:72% CF stock plunged -5.64% amid no clear ea - ✅ **KRYS** (2026-08-03) drop:-8.4% → Day16:+10.2% [-] conf:78% KRYS stock plunged despite EPS beat beca - ❌ **ICHR** (2026-08-04) drop:-11.7% → Day15:-12.9% [-] conf:78% ICHR plunged on Q2 revenue miss despite - ❌ **ULS** (2026-08-04) drop:-14.5% → Day15:-2.1% [-] conf:78% 市场将强劲Q2财报（EPS+5.4%, revenue+0.5% beat）误读 - ✅ **VERX** (2026-08-04) drop:-9.4% → Day15:+11.8% [-] conf:72% Despite beating Q2 EPS and revenue, VERX - ✅ **BHC** (2026-08-04) drop:-8.9% → Day15:+7.3% [-] conf:72% 市场因不明负面事件抛售BHC，叠加短期超买回调预期（前5日涨56%），形成恐慌性 - ✅ **VERA** (2026-08-04) drop:-7.2% → Day15:+7.9% [-] conf:72% 市场将Vera Therapeutics与无关的'Verafin'（被D-Wav - ❌ **ALHC** (2026-08-04) drop:-7.1% → Day15:-5.5% [-] conf:72% Market is pricing in material legal and - ❌ **SEDG** (2026-08-05) drop:-28.7% → Day14:-6.7% [-] conf:78% SolarEdge beat Q2 EPS but cut Q3 revenue - ✅ **TDC** (2026-08-05) drop:-22.8% → Day14:+5.5% [-] conf:78% Teradata missed Q3 EPS and revenue guida - ✅ **PODD** (2026-08-05) drop:-19.1% → Day14:+12.6% [-] conf:78% PODD crashed despite beating Q2 EPS and - ✅ **SPCX** (2026-08-05) drop:-12.9% → Day14:+27.3% [-] conf:78% SpaceX delivered a massive revenue beat - ✅ **LUMN** (2026-08-05) drop:-10.7% → Day14:+2.1% [-] conf:78% LUMN plunged on 'disappointing revenue d - ❌ **PINS** (2026-08-05) drop:-8.5% → Day14:-0.3% [-] conf:78% Pinterest beat Q2 EPS and revenue but is - ✅ **BLLN** (2026-08-06) drop:-38.8% → Day13:+0.4% [-] conf:72% BLLN plunged 38.8% on Q2 EPS miss ($0.15 - ✅ **HUBS** (2026-08-06) drop:-22.0% → Day13:+24.5% [-] conf:74% HubSpot beat EPS but cut full-year guida - ❌ **APP** (2026-08-06) drop:-19.8% → Day13:-6.6% [-] conf:72% AppLovin股价暴跌源于Q3财报营收不及预期（'revenue miss'） - ✅ **DDOG** (2026-08-06) drop:-19.1% → Day13:+2.5% [-] conf:78% Datadog delivered a strong beat-and-rais - ✅ **GRAL** (2026-08-06) drop:-16.7% → Day13:+20.5% [-] conf:78% Despite beating revenue estimates ($44.7 - ✅ **BYND** (2026-08-06) drop:-14.7% → Day13:+2634.6% [-] conf:74% Market punished BYND for a modest EPS mi - ✅ **NBIS** (2026-08-06) drop:-11.9% → Day13:+13.6% [-] conf:72% Market is punishing NBIS on profit-takin - ❌ **MARA** (2026-08-06) drop:-5.2% → Day13:-10.7% [-] conf:74% Market interprets insider selling, price - ✅ **BBY** (2026-08-06) drop:-5.3% → Day13:+11.3% [-] conf:72% Jefferies downgraded BBY to Hold citing - ❌ **LASR** (2026-08-07) drop:-23.9% → Day12:-16.3% [-] conf:78% LASR plunged on Q3 guidance miss ($63–73 - ❌ **TTD** (2026-08-07) drop:-21.9% → Day12:-1.1% [-] conf:74% Investors are increasingly bearish on th - ✅ **ARW** (2026-08-07) drop:-10.0% → Day12:+3.2% [-] conf:82% Despite strong Q2 beat and raised guidan - ✅ **TDS** (2026-08-07) drop:-9.4% → Day12:+6.7% [-] conf:78% TDS stock plunged -9.44% despite a massi - ✅ **ELAN** (2026-08-07) drop:-7.8% → Day12:+9.6% [-] conf:78% 市场将FDA紧急授权新药（screwworm drug）误读为短期成本压力或监管 - ❌ **XRAY** (2026-08-07) drop:-6.6% → Day12:-9.4% [-] conf:78% 尽管Q2 EPS大幅超预期（+50.1%）且营收小幅超预期（+1.6%），但市场 - ❌ **DPC** (2026-08-07) drop:-7.7% → Day12:-9.9% [-] conf:72% 市场因不明负面事件抛售DPC，但无实质性信息支撑，叙事缺失——仅存在泛泛的‘st - ✅ **SION** (2026-08-10) drop:-91.3% → Day9:+37.1% [-] conf:78% SION-719 failure in CF Phase 2/3 (Precis - ✅ **AXTI** (2026-08-10) drop:-15.8% → Day9:+0.4% [-] conf:72% AXTI plunged 15.85% amid unexplained pri - ❌ **COHR** (2026-08-10) drop:-12.3% → Day9:-13.5% [-] conf:74% AI optics stocks (COHR, LUMT) are sellin - ✅ **SLS** (2026-08-10) drop:-8.3% → Day9:+25.8% [-] conf:72% SLS plunged 8.3% amid unconfirmed negati - ❌ **DJT** (2026-08-10) drop:-9.0% → Day9:-10.3% [-] conf:72% Market interprets Crypto.com venture ter - ❌ **LCID** (2026-08-10) drop:-7.0% → Day9:-11.0% [-] conf:72% Lucid missed Q2 expectations and signale - ✅ **BRVE** (2026-08-10) drop:-8.2% → Day9:+5.4% [-] conf:78% 市场因不明负面事件抛售BRVE，疑与8-K公告内容相关，但公开新闻未披露实质性不 - ❌ **LIF** (2026-08-11) drop:-26.2% → Day8:-7.6% [-] conf:74% Market interpreted LIF's Q2 earnings cal - ❌ **NYAX** (2026-08-11) drop:-13.1% → Day8:-10.4% [-] conf:78% Market punished NYAX harshly for a large - ❌ **FA** (2026-08-11) drop:-10.0% → Day8:-0.5% [-] conf:78% 市场将Silver Lake大规模二级出售（12.5M股+潜在87.45M股）解 - ✅ **DFTX** (2026-08-11) drop:-8.9% → Day8:+10.1% [-] conf:74% Markets are pricing in high probability - ❌ **ALMS** (2026-08-11) drop:-8.2% → Day8:-3.6% [-] conf:78% 市场将积极临床 data（54% complete clearance at 4 - ❌ **TEO** (2026-08-11) drop:-7.0% → Day8:+0.0% [-] conf:78% Market interpreted Q2 earnings release a - ❌ **APP** (2026-08-11) drop:-5.6% → Day8:-2.2% [-] conf:72% AppLovin’s Q2 revenue miss and rising ex - ✅ **BRVE** (2026-08-11) drop:-9.2% → Day8:+16.0% [-] conf:72% 市场因信息真空与流动性扰动对BRVE进行无差别抛售，叠加小盘生物科技股在弱市中被 - ✅ **WRD** (2026-08-12) drop:-9.7% → Day7:+6.3% [-] conf:78% 市场因WRD Q2 2026财报‘EPS flat despite 92% Yo - ✅ **GRAL** (2026-08-12) drop:-8.6% → Day7:+7.9% [-] conf:72% 市场将GRAL与Guardant Health（GH）的正面MRD/screen - ❌ **LQDA** (2026-08-12) drop:-8.4% → Day7:-5.5% [-] conf:76% Market interpreted Q2 earnings as weak d - ❌ **NYAX** (2026-08-12) drop:-6.4% → Day7:-4.2% [-] conf:68% Barclays downgraded price target by $7 ( - ❌ **GENVR** (2026-08-12) drop:-6.5% → Day7:-17.2% [-] conf:58% 市场因信息真空与流动性恐慌抛售GENVR, 暗示潜在未披露风险或基本面恶化。 - ❌ **BSP** (2026-08-12) drop:-8.3% → Day7:-14.4% [-] conf:74% Market perceives BSP as overvalued and f - ❌ **LIME** (2026-08-12) drop:-6.9% → Day7:-0.3% [-] conf:78% Market conflates LIME (Neutron Holdings) - ✅ **SNAP** (2026-08-12) drop:-5.6% → Day7:+1.4% [-] conf:74% Snap is materially exposed to escalating - ✅ **CLBT** (2026-08-13) drop:-33.4% → Day6:+10.8% [-] conf:74% CLBT plunged 33% on Q2 revenue miss and - ❌ **LFTO** (2026-08-13) drop:-18.7% → Day6:-4.5% [-] conf:78% LFTO plunged on Q2 2026 earnings despite - ✅ **BSP** (2026-08-13) drop:-17.1% → Day6:+3.2% [-] conf:78% Despite a strong Q2 EPS beat (+70% vs es - ✅ **BLTE** (2026-08-13) drop:-8.5% → Day6:+3.5% [-] conf:78% 市场将FDA授予Tinlarebant优先审评（重大利好）与Q2亏损扩大（-8% - ❌ **CW** (2026-08-13) drop:-5.4% → Day6:-1.9% [-] conf:78% Market is pricing in unexplained negativ - ✅ **LQDA** (2026-08-13) drop:-8.5% → Day6:+5.7% [-] conf:72% 市场因分析师评级分歧（LifeSci downgrade amid multip - ✅ **KOD** (2026-08-13) drop:-7.9% → Day6:+0.0% [-] conf:74% 市场将Q2净亏损$65.6M（同比扩大）和现金余额$125.9M解读为财务压力加 - ❌ **GENVR** (2026-08-14) drop:-16.2% → Day5:-10.0% [-] conf:72% 市场因不明负面事件恐慌抛售Gen Digital，叠加流动性枯竭（成交量骤降91 - ✅ **VCRE** (2026-08-14) drop:-12.9% → Day5:+10.2% [-] conf:72% 市场因不明负面事件或 liquidity-driven panic sellin - ❌ **UCTT** (2026-08-14) drop:-8.1% → Day5:-11.6% [-] conf:78% Market interpreted the $400M ATM equity - ✅ **WIX** (2026-08-14) drop:-7.3% → Day5:+5.2% [-] conf:72% Market is pricing in litigation risk and - ✅ **LIME** (2026-08-14) drop:-6.3% → Day5:+0.7% [-] conf:78% Market is pricing in undisclosed negativ - ✅ **DOCS** (2026-08-14) drop:-6.0% → Day5:+3.0% [-] conf:72% 市场在消化DOCS近期暴涨后的获利回吐，叠加对AI叙事可持续性的短期怀疑，但无明 - ❌ **HAWK** (2026-08-14) drop:-5.2% → Day5:-5.8% [-] conf:78% Despite beating EPS and revenue estimate - ✅ **DUOL** (2026-08-14) drop:-7.8% → Day5:+11.2% [-] conf:78% Market is punishing DUOL for the Animade - ✅ **PGEN** (2026-08-14) drop:-6.0% → Day5:+16.9% [-] conf:72% Precigen’s recent sharp rally has made s - ✅ **GENVR** (2026-08-17) drop:-23.6% → Day2:+8.4% [-] conf:72% 市场因不明负面催化剂集体抛售GENVR, 暗示存在未披露的重大风险或流动性危机 - ❌ **CLOV** (2026-08-17) drop:-7.9% → Day2:-0.8% [-] conf:78% 市场因Q2 2026 earnings call interpreting 'b - ✅ **LFTO** (2026-08-17) drop:-9.5% → Day2:+0.3% [-] conf:72% 市场因不明负面催化剂集体抛售LFTO，叠加板块疲软，形成恐慌性超调；叙事缺失具体 - ❌ **TENB** (2026-08-17) drop:-6.9% → Day2:-0.8% [-] conf:72% 市场因缺乏明确负面催化剂而恐慌性抛售，叠加机构持仓分歧（Firetrail bu - ✅ **FA** (2026-08-17) drop:-6.8% → Day2:+5.0% [-] conf:72% 市场因不明负面催化剂抛售FA，叠加超调情绪，但无实质性利空信息支撑 - ✅ **IRTC** (2026-08-17) drop:-6.9% → Day2:+4.7% [-] conf:72% 市场因‘法律调查’和‘内幕交易/信义义务质疑’传闻恐慌性抛售，将未证实的监管风险 - ✅ **CLBT** (2026-08-17) drop:-5.6% → Day2:+6.9% [-] conf:72% 市场因分析师降级和‘增长前景黯淡’叙事抛售CLBT，认为其核心执法软件业务面临需 - ❌ **RDDT** (2026-08-17) drop:-6.4% → Day2:-8.3% [-] conf:78% Reddit sold off alongside broader market **Accuracy: 173/289 (60%)** ### CORRECT (12 signals) - ✅ **IONS** (2026-07-09) drop:-23.4% → Day29:-12.9% [-] conf:92% Ionis/AZ's eplontersen failed Phase 3 in - ❌ **RGTIW** (2026-07-13) drop:-18.8% → Day30:+31.4% [-] conf:92% Rigetti plunged alongside other speculat - ❌ **RGTIW** (2026-07-14) drop:-7.5% → Day30:+19.2% [-] conf:92% 量子计算板块遭遇系统性风险出清，Rigetti被连带抛售，市场将其与IonQ、D - ❌ **NFLX** (2026-07-17) drop:-7.3% → Day28:+13.3% [-] conf:87% Netflix beat EPS but cut Q3 revenue grow - ❌ **TSLA** (2026-07-23) drop:-14.4% → Day27:+9.0% [-] conf:87% Tesla missed Q2 2026 EPS and auto margin - ❌ **COIN** (2026-07-31) drop:-8.0% → Day19:+5.4% [-] conf:92% COIN stock crashed due to Q2 earnings mi - ❌ **LMAT** (2026-08-05) drop:-22.9% → Day14:+2.7% [-] conf:87% LMAT Q2 EPS miss (-6.3%) and meaningful - ✅ **LCID** (2026-08-05) drop:-15.1% → Day14:-11.8% [-] conf:87% Lucid missed Q2 expectations and slashed - ❌ **FLUT** (2026-08-05) drop:-14.2% → Day14:+10.6% [-] conf:87% Flutter missed Q2 EPS by 18% ($0.49 vs $ - ❌ **BYND** (2026-08-11) drop:-21.1% → Day8:+3368.3% [-] conf:92% Beyond Meat’s 1-for-30 reverse stock spl - ❌ **DJT** (2026-08-12) drop:-6.7% → Day7:+0.4% [-] conf:87% DJT’s Q2 revenue growth (89% y/y) is ove - ❌ **ZBIO** (2026-08-13) drop:-8.7% → Day6:+11.9% [-] conf:87% ZBIO missed Q2 EPS by 64% and revenue by **Accuracy: 2/12 (17%)** ### UNCLEAR (7 signals) - ❓ **RGC** (2026-07-06) drop:-7.8% → Day30:+0.5% [-] conf:52% 市场将DOJ监管调查解读为实质性业务风险与估值崩溃信号，叠加短期做空情绪与流动性 - ❓ **NAMSW** (2026-07-20) drop:-11.5% → Day30:+nan% [-] conf:42% 市场因不明负面事件抛售NAMSW，但无公开信息支撑，形成真空式恐慌。 - ❓ **BDRX** (2026-07-21) drop:-16.9% → Day29:-26.0% [-] conf:42% 市场因不明负面事件抛售BDRX, 暗示存在未披露的重大风险或 pipeline - ❓ **SLBT** (2026-07-22) drop:-9.3% → Day28:-21.7% [-] conf:42% 市场因不明负面事件抛售SLBT, 暗示存在未披露的重大风险（如临床失败、FDA警 - ❓ **DPC** (2026-07-28) drop:-5.7% → Day22:+3.0% [-] conf:42% 市场因不明负面消息或 liquidity-driven panic 抛售 DPC - ❓ **NAMSW** (2026-07-28) drop:-12.8% → Day22:+nan% [-] conf:42% 市场因不明负面事件或 liquidity-driven panic sellin - ❓ **NAMSW** (2026-08-17) drop:-8.1% → Day2:+nan% [-] conf:42% 市场因不明负面事件（可能与SEC 8-K披露有关）抛售NAMSW, 暗示监管风险 ## Missed Opportunities These were NOT flagged as MISJUDGMENT but recovered significantly: - **RGTIW** judged CORRECT → Day30:+31.4% (Rigetti plunged alongside other speculat) - **RGTIW** judged CORRECT → Day30:+19.2% (量子计算板块遭遇系统性风险出清，Rigetti被连带抛售，市场将其与IonQ、D) - **NFLX** judged CORRECT → Day28:+13.3% (Netflix beat EPS but cut Q3 revenue grow) - **TSLA** judged CORRECT → Day27:+9.0% (Tesla missed Q2 2026 EPS and auto margin) - **COIN** judged CORRECT → Day19:+5.4% (COIN stock crashed due to Q2 earnings mi) - **FLUT** judged CORRECT → Day14:+10.6% (Flutter missed Q2 EPS by 18% ($0.49 vs $) - **BYND** judged CORRECT → Day8:+3368.3% (Beyond Meat’s 1-for-30 reverse stock spl) - **ZBIO** judged CORRECT → Day6:+11.9% (ZBIO missed Q2 EPS by 64% and revenue by)